Ambuja Cements Limited (AMBUJACEM) — Financial Results | 29 April 2025(3 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Financial Results 🔴 High Importance Neutral 📄 PDF

Ambuja Cements reported consolidated revenue of ₹37,649.01 crores for FY2025, up 17.98% YoY, with net profit after tax of ₹5,158.41 crores. The company declared a dividend of ₹2 per share and scheduled its AGM for June 26, 2025. It completed major acquisitions including Orient Cement and Penna Cement, and received tax and incentive refunds totaling ₹1,054.77 crores. The auditor issued an unmodified opinion with no material uncertainty on going concern.

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Ambuja Cements reported consolidated revenue of ₹13,265.53 crores for Q4 FY2025, reflecting a 32% YoY growth driven by strong domestic demand and operational efficiency. The company highlighted improved profitability and sustained market leadership in the infrastructure sector.

3 Financial Results 🔴 High Importance Neutral 📄 PDF

Ambuja Cements reported consolidated revenue of ₹35,045 crores for FY'25, up 6% YoY, with PAT at ₹5,158 crores (up 9% YoY). The company achieved record volume of 65.2 Mn T (up 10% YoY) and EBITDA of Rs 1,868 Cr in Q4 (up 10% YoY). Cash reserves stood at Rs 10,125 Cr, supporting expansion plans including 118 MTPA capacity by FY26. The Board recommended a dividend of Rs 2 per share.

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMBUJACEM — Free

Free account · 2 AI queries/day